Pricing Log in Create free account
Saturday 17 October 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Danaher Corporation (DHR) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 9, 2026 5.02 Departure or appointment of directors or officers; 8.01 Other events Officer departure
8-K Jul 31, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jul 21, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 26, 2026 P1I2: 33 added · 7 removed · 48 modified
P2I1A: 1 modified
8-K Jun 3, 2026 2.03 Creation of a direct financial obligation; 8.01 Other events
8-K May 5, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Apr 22, 2026 1.01 Entry into a material definitive agreement; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 21, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 27, 2026
8-K Apr 16, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 2 added · 4 removed · 42 modified
1A: 8 added · 9 removed · 49 modified
7: 23 added · 13 removed · 74 modified
8-K Feb 16, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 5, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Jan 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 6, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Sep 26, 2025
8-K Oct 21, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 9, 2025 5.03 Amendments to the articles or bylaws; change in fiscal year; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 27, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.